OR HB3817

Oregon Health Authority and Department of Veterans' Affairs must study ibogaine consumption for treating PTSD, major depressive disorder, anxiety disorders, and substance use disorders

Ibogaine is defined as a naturally occurring indole alkaloid extracted from the root bark of the Tabernanthe iboga shrub

Report due to Legislative Assembly health care committees by September 15, 2029, covering safety/efficacy research, dosing recommendations, provider training requirements, client screening criteria, and program funding mechanisms

Study must address ibogaine sourcing, production, testing, tracking systems, and data reporting on consumption and client outcomes

Act sunsets on January 2, 2030